Early Diagnosis of Breast Cancer
Challenged by a large uncertainty on Positive Predictive Value in ACR 4 category (2% – 95%)
Leads to overconsumption of Macrobiopsies which are :
- Deleterious for the patient
- Time-consuming for the doctor
- Costly for the Health System
Cancer detected at an ADVANCED STAGE
Cancer detected at an EARLY STAGE
millions mammograms WW per year
millions mammograms contain microcalcifications
millions microcalcifications are suspect ACR>4
millions microcalcifications are benign
First clinical evaluation results
Phase Imaging
BRIGHTX
Absorption Imaging
Commercial Equipment
Exploration of individuel microcalcification
We have performed a first clinical evaluation on fifty breast Macro-Biopsies.
Our Phase contrast imaging technique demonstrates better performances than classic absorption technique and the main interest of these results is that our phase contrast images allow radiologists to easily characterize microcalcifications into benign and malignant directly on the Mammograms.
Phase Contrast Imaging paves the way for a new semiology to characterize microcalcifications
About Us
Our research center, located in Talence, Gironde, is dedicated to advancing medical imaging technologies.
With a growing team of experts and expanding partnerships with leading institutions, we drive innovation to enhance diagnostic precision.
Our commitment to research fosters groundbreaking solutions for early disease detection and improved patient care.
